1.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: ECF/endo-MGC, NCT00595972
|
|
2.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: Endostar B-01, XOBCR01, NCT00604435
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: XYL014, NCT00708812
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-69, NCT00912392
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: DP-EN-RT, NCT01218594
|
|
6.
|
Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: XIANSHENG, NCT01347424
|
|
7.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000067532, P30CA014520, WCCC-CO-99910, NCI-T99-0055, T99-0055, NCT00004872
|
|
8.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-93, NCT01531790
|
Mobile | Español
